alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.

By Mark A. Rubin, Ming Zhou, S. Dhanasekaran, S. Varambally, T. Barrette, M. Sanda, K. Pienta, Debashis Ghosh, Arul M. Chinnaiyan. Journal of the American Medical Association (JAMA), 2002

609 citations recorded by the source corpus.

Subfields: Molecular Biology, Pulmonary and Respiratory Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/1e93268fec6324c49b130795c42a650129d1bd14

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Arul M. Chinnaiyan
2. Debashis Ghosh
3. Mark A. Rubin
4. R. Jenkins
5. Chad Creighton
6. Timothy Triche
7. Ronglai Shen
8. Christian Borgelt

In Pulmonary and Respiratory Medicine

1. Arul M. Chinnaiyan
2. Mark A. Rubin
3. Timothy Triche

Citations in the corpus

• Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases (2004, background): “AMACR, a new molecular marker, has previously been shown to be a highly sensitive marker for clinically localized prostate cancer and colorectal cancer ( 3 , 21).”
• Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy (2013, result): “The performance of GC was compared to that of previously published gene signatures [11–13,15,16,18–24,28–30] and individual genomic markers associated with prostate cancer progression including CHGA [43], DAB2IP [44], GOLPH2 [45], PAP [46], ETV1 and ERG [47], KI-67 [48], PSA [49], PSCA [50], PSMA [5”